Original research · CC-BY-4.0 · Version 1.0
An audit of pricing disclosure across 18 US menopause telehealth providers. Cash prices, insurance acceptance, state coverage, and a proprietary 1-10 Cost Transparency Score for every brand.
Methodology. Between 2026-06 and 2026-06-25, we audited every US telehealth provider in our menopause coverage category (18 brands) against five publicly-checkable pricing disclosures: starting price, pricing model, excluded fees, cancellation terms, and state availability. Prices reflect the lowest publicly-listed monthly tier from the brand’s own marketing site.
Top findings. 17% of menopause telehealth brands do not publish a starting price. Among those that do, the cash-pay median is $50/month. Only 22% bill insurance directly. The mean Cost Transparency Score is 5.2/10.
Recommendations. Patients should reject any provider unwilling to publish a starting price, a written cancellation policy, and a list of costs excluded from the headline figure. Regulators and payers should note that cash-pay dispersion for identical HRT protocols has widened, not narrowed, since 2024.
| Brand | Starting price | Accepts insurance | States available | Cost transparency (1-10) | Pricing model |
|---|---|---|---|---|---|
| 1st Optimal | $89/mo | No | 30 states | 5 | Per-visit |
| Alloy Women's Health | $49/mo | No | 28 states | 6 | Subscription |
| Cerebral (Menopause) | $99/mo | Yes | All 50 + DC | 5 | Concierge |
| Defy Medical | $195/mo | No | All 50 + DC | 6 | Subscription |
| Elektra Health | $30/mo | No | 30 states | 6 | Subscription |
| Evernow | $49/mo | No | All 50 + DC | 6 | Subscription |
| Gennev | Not published | Yes | 20 states | 4 | Hybrid |
| Hims & Hers (Menopause) | $50/mo | No | All 50 + DC | 5 | Hybrid |
| Hone Health (Women) | $45/mo | No | All 50 + DC | 6 | Subscription |
| Interlude | $175/mo | No | 8 states | 5 | Hybrid |
| Midi Health | Not published | Yes | 10 states | 4 | Insurance-billed |
| Ms. Medicine | $250/mo | No | 10 states | 6 | Subscription |
| Odela | $55/mo | No | 30 states | 6 | Subscription |
| Stella Health | $35/mo | No | 5 states | 5 | Subscription |
| Tia Women’s Health | Not published | Yes | 5 states | 4 | Hybrid |
| Vira Health | $19/mo | No | 8 states | 5 | Per-visit |
| Winona | $25/mo | No | All 50 + DC | 5 | Subscription |
| Womaness Care | $75/mo | No | All 50 + DC | 5 | Concierge |
Universe defined as any US-licensed telehealth provider whose marketing site includes menopause or perimenopause as a named clinical service line, operating status “active” as of 2026-06-25. Five facts captured per brand from public sources: starting monthly price, insurance acceptance, US states served, pricing model, and written cancellation policy. No third-party aggregators. Ambiguous copy resolved via brand outreach for written clarification; non-responsive brands coded “not published” rather than imputed.
Every data point captured twice by two editors independently, then reconciled. Discrepancies resolved by re-checking source pages and archiving screenshots. Data collection closed 2026-06-25; report published 2026-07-02.
ClearHormones. (2026). 2026 State of Menopause Telehealth Pricing Transparency Report. Retrieved 2026-07-02 from https://clearhormones.com/reports/menopause-pricing-transparency-2026
@techreport{clearhormones_menopause_pricing_2026,
title = {2026 State of Menopause Telehealth Pricing Transparency Report},
author = {{ClearHormones Editorial}},
year = {2026},
url = {https://clearhormones.com/reports/menopause-pricing-transparency-2026},
note = {Licensed CC-BY-4.0}
}